Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways

por Chen, Yi-Jin, Wang, Wen-Hung, Wu, Wan-Yu, Hsu, Chia-Chi, Wei, Ling-Rung, Wang, Sheng-Fan, Hsu, Ya-Wen, Liaw, Chih-Chuang, Tsai, Wan-Chi
Publicado 2017